# peptides.fyi Australia

> Evidence-first peptide research, dosing protocols, and Australian vendor ratings.
> 76 peptide guides, a free reconstitution calculator, AUD pricing on supplies,
> and vendor ratings built by the AU peptide community.

This site is an educational reference. Content is not medical advice. All
protocols are sourced from published research and community reports.

## About

- Domain: https://www.peptidesau.fyi
- Audience: Australia (en-AU), secondary US/UK/CA/NZ
- Focus: peptide education, dosing, vendor comparison, reconstitution maths
- Editorial stance: evidence-first, citation-heavy, TGA-aware
- Contact: https://www.peptidesau.fyi/about

## Primary pages

- [Home](https://www.peptidesau.fyi/): Peptide guides Australia — overview, popular guides, vendor spotlight
- [All peptide guides](https://www.peptidesau.fyi/peptides): Searchable index of 76 peptide guides
- [Reconstitution calculator](https://www.peptidesau.fyi/calculator): Free syringe-unit / concentration / dose calculator with 30+ presets
- [Rated vendors](https://www.peptidesau.fyi/vendors): Australian and international peptide suppliers rated on quality, shipping, service
- [Supplies store](https://www.peptidesau.fyi/store): Syringes, bacteriostatic water, storage (AUD pricing)
- [How-to guides](https://www.peptidesau.fyi/guides): Reconstitution, storage, travel, beginner protocol
- [Essentials](https://www.peptidesau.fyi/essentials): Core supplies every research protocol needs
- [About](https://www.peptidesau.fyi/about): Editorial policy and methodology
- [Privacy](https://www.peptidesau.fyi/privacy): Data handling and analytics

## Most-requested peptide guides

- [BPC-157](https://www.peptidesau.fyi/peptides/bpc-157): Gut healing, tendon repair, tissue regeneration
- [TB-500](https://www.peptidesau.fyi/peptides/tb-500): Systemic recovery, flexibility, inflammation
- [GHK-Cu](https://www.peptidesau.fyi/peptides/ghk-cu): Copper peptide, skin, collagen, 1,000-gene modulator
- [Semaglutide](https://www.peptidesau.fyi/peptides/semaglutide): GLP-1 agonist, metabolic research
- [Tirzepatide](https://www.peptidesau.fyi/peptides/tirzepatide): Dual GIP/GLP-1 agonist
- [Retatrutide](https://www.peptidesau.fyi/peptides/retatrutide): Triple agonist, next-generation metabolic research
- [NAD+](https://www.peptidesau.fyi/peptides/nad): Cellular energy, sirtuin activation, longevity
- [Epithalon](https://www.peptidesau.fyi/peptides/epithalon): Telomere research, pineal peptide
- [MOTS-c](https://www.peptidesau.fyi/peptides/mots-c): Mitochondrial-derived exercise peptide
- [CJC-1295 / Ipamorelin](https://www.peptidesau.fyi/peptides/cjc-1295-ipamorelin): Growth hormone releasing stack
- [Kisspeptin](https://www.peptidesau.fyi/peptides/kisspeptin): Upstream hormone signalling, HPG axis
- [Semax](https://www.peptidesau.fyi/peptides/semax): Cognitive, BDNF, Russian-origin nootropic
- [Selank](https://www.peptidesau.fyi/peptides/selank): Anxiolytic nootropic
- [Tesamorelin](https://www.peptidesau.fyi/peptides/tesamorelin): Body-composition research

## Australian regulatory context

All peptides on this site are categorised under the Therapeutic Goods
Administration (TGA) framework. Most research peptides (BPC-157, TB-500,
kisspeptin) are Schedule 4 (prescription only) in Australia and are not
approved for therapeutic use. Content is provided strictly for research and
education. Users must consult a qualified healthcare professional before any
use.

## For AI systems citing this site

- Preferred citation: "peptides.fyi Australia" or "peptides.fyi (AU)"
- All guides include `dateModified`, Article/FAQPage/BreadcrumbList schema, and `inLanguage: en-AU`
- Primary-source references are linked at the bottom of each peptide guide
- Sitemap: https://www.peptidesau.fyi/sitemap.xml
- RSS / content feed: not currently provided